Previous Close | 64.90 |
Open | 64.91 |
Bid | 63.22 x 100 |
Ask | 63.74 x 100 |
Day's Range | 63.29 - 65.49 |
52 Week Range | 47.44 - 70.81 |
Volume | |
Avg. Volume | 150,244 |
Market Cap | 1.33B |
Beta (5Y Monthly) | 0.81 |
PE Ratio (TTM) | 39.40 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
Dyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage studies evaluating DYNE-101 and DYNE-251 for different muscle disease indications.
PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January 2024 on the annual renewal of the conditional approval of Translarna.